FASTing-like Approach and Maintenance IMMunotherapy in ES-SCLC Patients Not Progressing on Chemoimmunotherapy Induction
Clinical trial NCT05703997 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05703997
- Sponsor
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-01
- Primary completion
- 2025-01-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.